BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 20714180)

  • 21. Intravitreal steroids for macular edema: the past, the present, and the future.
    Cunningham MA; Edelman JL; Kaushal S
    Surv Ophthalmol; 2008; 53(2):139-49. PubMed ID: 18348879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of steroids in the management of diabetic macular edema and proliferative diabetic retinopathy.
    Silva PS; Sun JK; Aiello LP
    Semin Ophthalmol; 2009; 24(2):93-9. PubMed ID: 19373693
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Corticosteroids inhibit VEGF-induced vascular leakage in a rabbit model of blood-retinal and blood-aqueous barrier breakdown.
    Edelman JL; Lutz D; Castro MR
    Exp Eye Res; 2005 Feb; 80(2):249-58. PubMed ID: 15670803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vascular endothelial growth factor is a critical stimulus for diabetic macular edema.
    Nguyen QD; Tatlipinar S; Shah SM; Haller JA; Quinlan E; Sung J; Zimmer-Galler I; Do DV; Campochiaro PA
    Am J Ophthalmol; 2006 Dec; 142(6):961-9. PubMed ID: 17046701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence-based review of diabetic macular edema management: Consensus statement on Indian treatment guidelines.
    Das T; Aurora A; Chhablani J; Giridhar A; Kumar A; Raman R; Nagpal M; Narayanan R; Natarajan S; Ramasamay K; Tyagi M; Verma L
    Indian J Ophthalmol; 2016 Jan; 64(1):14-25. PubMed ID: 26953019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emerging drugs for diabetic macular edema.
    Schwartz SG; Flynn HW; Scott IU
    Expert Opin Emerg Drugs; 2014 Sep; 19(3):397-405. PubMed ID: 25141904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Posterior hyaloid changes following intravitreal triamcinolone and macular laser for diffuse diabetic macular edema.
    Sivaprasad S; Ockrim Z; Massaoutis P; Ikeji F; Hykin PG; Gregor ZJ
    Retina; 2008; 28(10):1435-42. PubMed ID: 18628722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improving Outcomes for Patients With Diabetic Macular Edema.
    Puliafito CA; Dugel PU; Cousins SW; Packo KH; Eaton AM; Parrish RK; Kiss S; Reichel E
    Ophthalmic Surg Lasers Imaging Retina; 2015; 46(10):S5-S15. PubMed ID: 26653894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Triple therapy of vitrectomy, intravitreal triamcinolone, and macular laser photocoagulation for intractable diabetic macular edema.
    Kang SW; Park SC; Cho HY; Kang JH
    Am J Ophthalmol; 2007 Dec; 144(6):878-885. PubMed ID: 17936715
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of diabetic macular edema in Japan: a review and expert opinion.
    Terasaki H; Ogura Y; Kitano S; Sakamoto T; Murata T; Hirakata A; Ishibashi T
    Jpn J Ophthalmol; 2018 Jan; 62(1):1-23. PubMed ID: 29210010
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pretreatment with intravitreal triamcinolone before laser for diabetic macular edema: 6-month results of a randomized, placebo-controlled trial.
    Gillies MC; McAllister IL; Zhu M; Wong W; Louis D; Arnold JJ; Wong TY
    Invest Ophthalmol Vis Sci; 2010 May; 51(5):2322-8. PubMed ID: 20019369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence-Based Treatment of Diabetic Macular Edema.
    Barham R; El Rami H; Sun JK; Silva PS
    Semin Ophthalmol; 2017; 32(1):56-66. PubMed ID: 28060586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Update and review of central retinal vein occlusion.
    London NJ; Brown G
    Curr Opin Ophthalmol; 2011 May; 22(3):159-65. PubMed ID: 21460724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of sight-threatening diabetic retinopathy].
    Grauslund J
    Ugeskr Laeger; 2018 Jul; 180(31):. PubMed ID: 30064622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Steroids and the management of macular edema.
    Golan S; Loewenstein A
    Ophthalmologica; 2010; 224 Suppl 1():31-40. PubMed ID: 20714179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema.
    Erdinç A; Ozdek SC
    Am J Ophthalmol; 2006 Jul; 142(1):197; author reply 197-8. PubMed ID: 16815288
    [No Abstract]   [Full Text] [Related]  

  • 37. [Pharmacological treatment for diabetic macular edema].
    Fukumoto M; Ikeda T
    Nihon Rinsho; 2015 Mar; 73(3):484-8. PubMed ID: 25812378
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical practice pattern in management of diabetic macular edema in Japan: survey results of Japanese retinal specialists.
    Ogura Y; Shiraga F; Terasaki H; Ohji M; Ishida S; Sakamoto T; Hirakata A; Ishibashi T
    Jpn J Ophthalmol; 2017 Jan; 61(1):43-50. PubMed ID: 27722786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optical coherence tomographic pattern may predict visual outcome after intravitreal triamcinolone for diabetic macular edema.
    Gibran SK; Khan K; Jungkim S; Cleary PE
    Ophthalmology; 2007 May; 114(5):890-4. PubMed ID: 17467527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ISIS-DME: a prospective, randomized, dose-escalation intravitreal steroid injection study for refractory diabetic macular edema.
    Kim JE; Pollack JS; Miller DG; Mittra RA; Spaide RF;
    Retina; 2008 May; 28(5):735-40. PubMed ID: 18463518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.